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H3R8 methylationAccumulation of S-adenosylhomocysteine (AdoHcy), the homocysteine (Hcy) precursor and a potent
methyltransferase inhibitor, may mediate the neurological and vascular complications associated with
elevated Hcy. Protein arginine methylation is a crucial post-translational modiﬁcation and generates
monomethylarginine (MMA) and dimethylarginine (asymmetric, ADMA, and symmetric, SDMA) residues.
We aimed at determining whether protein arginine methylation status is disturbed in an animal model of
diet-induced hyperhomocysteinemia (HHcy). HHcy was achieved by dietary manipulation of Wistar rats:
methionine-enrichment (HM), B vitamins deﬁciency (LV), or both (HMLV). Total Hcy, S-adenosylmethionine
(AdoMet), AdoHcy, MMA, ADMA and SDMA concentrations in plasma or tissues (heart, brain and liver) were
determined by adequate high-performance liquid chromatography or liquid chromatography-electrospray
ionization-tandem mass spectrometry methods. Moreover, in tissues from the HMLV group, histone arginine
asymmetric dimethylation was evaluated by Western blotting, and the histone methylation marks
H3R17me2a, H3R8me2a and H4R3me2a were studied. HHcy was induced by all special diets, with elevation of
AdoHcy concentrations in liver (LV and HMLV) and heart (HMLV) (all versus control). Plasma ADMA levels
were lower in all hyperhomocysteinemic animals. Protein-incorporated ADMA levels were decreased in brain
and in heart (both for the LV and HMLV groups). Moreover, in brain of animals exposed to the HMLV diet, the
H3R8me2a mark was profoundly decreased. In conclusion, our results show that diet-induced Hcy elevation
disturbs global protein argininemethylation in a tissue-speciﬁcmanner and affects histone argininemethylation
in brain. Future research is warranted to disclose the functional implications of the global protein and histone
arginine hypomethylation triggered by Hcy elevation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Elevation of total homocysteine (tHcy) in plasma, or hyper-
homocysteinemia (HHcy), has been extensively associated with cardio-
vascular andneurological diseases [1]. Nevertheless, the underlying basis
of these associations remains largely unknown and may involve several
mechanisms. It has been hypothesized that homocysteine (Hcy) eleva-
tion disturbs the methylation capacity of the cell due to accumulationhemistry, Metabolic Unit, VU
e Netherlands. Tel.: +31 20
thors.
l rights reserved.of its precursor S-adenosylhomocysteine (AdoHcy). AdoHcy is a compet-
itive inhibitor of most methyltransferases that use AdoMet and, for
this reason, a decreased AdoMet/AdoHcy ratio often indicates a re-
duced cellular methylation capacity [2]. Hcy is formed from methio-
nine (Fig. 1), which is ﬁrst activated by condensation with ATP to
form S-adenosylmethionine (AdoMet), the methyl group donor for
a wide variety of cellular methylation reactions. Upon transfer of
the methyl group, AdoMet is converted to AdoHcy, which is hydro-
lyzed by AdoHcy hydrolase to adenosine and Hcy [1]. Importantly,
this reaction is reversible and AdoHcy synthesis is thermodynami-
cally favored over its hydrolysis, but due to efﬁcient removal of the
products, the reaction proceeds in the hydrolysis reaction [3]. Genetic
defects in enzymes involved in the catabolism of Hcy, or deﬁciencies in
cofactors required for those enzymes, hamper Hcy clearance and lead
Fig. 1. Schematic representation of the homocysteine metabolism. Methionine is converted to S-adenosylmethionine (AdoMet) by methionine adenosyltransferase (MAT). AdoMet
serves as methyl group donor in a horde of methylation reactions in which it is converted to S-adenosylhomocysteine (AdoHcy). The latter may be subsequently hydrolyzed by
S-adenosylhomocysteine hydrolase (SAHH) to homocysteine (Hcy) and adenosine. Under normal physiological conditions, homocysteine is readily exported or catabolized through
the transsulfuration and remethylation pathways. Deﬁciencies in cofactors that are required for these pathways, namely B vitamins, prevent the biochemical transformation of
Hcy and may induce AdoHcy accumulation, which may result in cellular hypomethylation. CBS = cystathionine beta-synthase. MS = methionine synthase. MTHFR =
methylenetetrahydrofolate reductase. SHMT = serine hydroxymethyltransferase. BHMT = betaine-homocysteine S-methyltransferase.
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ronment [4]. Several lines of evidence have shown that DNA is a tar-
get for the hypomethylating effect of AdoHcy accumulation in the
context of HHcy. It has been observed that, in humans, plasma tHcy
concentration correlates positively with AdoHcy level and negatively
with lymphocyte global DNA methylation [5,6]. Furthermore, mice
deﬁcient in methylenetetrahydrofolate reductase (MTHFR), an enzyme
crucial for the folate-dependent remethylation of Hcy to methionine,
are hyperhomocysteinemic and exhibit global DNA hypomethylation,
decreased AdoMet levels and elevated AdoHcy levels, in several tissues
[7]. Similarly, mice lacking activity of cystathionine beta-synthase
(CBS), a key enzyme in the conversion of Hcy to cysteine through the
transsulfuration pathway, have severely elevated plasma tHcy levels,
high hepatic levels of AdoHcy and global DNA hypomethylation in
liver [8]. However, the impact of Hcy elevation onmethyl transfer reac-
tions other than DNAmethylation has been largely overlooked. Protein
argininemethylation is an important andwidespreadpost-translational
modiﬁcation that increases the structural diversity of proteins and
modulates their function. Protein arginine methylation is catalyzed
by protein arginine methyltransferases (PRMTs), which are divided
into two major classes depending on the type of dimethylarginine
they generate. Both type I and type II enzymes monomethylate the
guanidinium nitrogen of arginine residues in proteins, forming
NG-monomethylarginine (MMA). The generation of asymmetric NG,
NG-dimethylarginine (ADMA) is catalyzed by type I enzymes, whereas
type II enzymes catalyze the formation of symmetric NG,N′G-
dimethylarginine (SDMA) [9]. PRMTs target numerous proteins involved
in transcriptional regulation, signal transduction, RNA metabolism and
DNA repair [9]. Particularly, histone targeting by PRMTs is an important
epigenetic mechanism of gene expression regulation. The relationshipsbetween histone arginine methylation patterns and gene expression
are intricate. Nevertheless, asymmetric dimethylation such as that of
histone H3 at arginine residues 2 (H3R2), 17 (H3R17) and 26 (H3R26)
is generally associated with transcriptionally permissive chromatin,
while symmetric dimethylation (e.g. PRMT5-catalyzed symmetric
dimethylation of H3R8 and H4R3) associates with heterochromatin for-
mation and gene repression [10]. It is currently unknown whether Hcy
elevation leads to inhibition of PRMTs activity via AdoHcy accumulation,
thereby reducing histonic or non-histonic arginine methylation.
We have previously observed that AdoHcy accumulation in
human endothelial cells induces hypomethylation of arginine resi-
dues in proteins to a greater extent than DNA hypomethylation
[11]. This observation led us to hypothesize that protein arginine
hypomethylation is a new player in the pathophysiology of HHcy.
The present study was designed to disclose the impact of elevated
Hcy on global protein and histone arginine methylation status in dif-
ferent tissues (liver, heart and brain) obtained from a murine model
in which HHcy was induced by diets enriched in methionine, B vita-
mins deﬁciency and the combination of methionine enrichment
with B vitamins deﬁciency.
2. Materials and methods
2.1. Animals, diets and preparation of tissue homogenates
The studies presented here were performed in adult femaleWistar
rats with a body weight of approximately 250 g (Iffa Credo, Brussels,
Belgium), in accordance with local prescriptions and the NIH Guide for
the Care and Use of Laboratory Animals. For 8 weeks, the animals were
fed one of the following diets: standard rodent chow (n = 19)
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in B vitamins (folic acid, B6 and B12) (n = 8) (LV); diet enriched in
methionine and deﬁcient in B vitamins (folic acid, B6 and B12) (n = 8)
(HMLV) (Table 1). Then the animals were anesthetized with
thiobutabarbital (Inactin, RBI; 100 mg/kg IP) and blood was collected
by cardiac puncture. Samples of liver, heart and brain were obtained
and cut into small pieces using a surgical blade, weighed and stored at
−80 °C until use.
Tissue homogenate was prepared on ice in 0.1 N HCl (10 mL/g wet
weight of tissue) with an OMNI-2000 homogenizer (Omni 2000,
OMNI International, Waterbury, CT, USA). Immediately after homog-
enization, a part of the homogenate was processed for AdoMet and
AdoHcy determination as described below. The remainder was
aliquoted and stored at−80 °C until further use. For protein concen-
tration determination, an aliquot was thawed, centrifuged at 12,000 g
at 4 °C for 5 min to remove debris and the supernatant was analyzed
with the Bicinchoninic Acid Protein Assay Kit (Pierce, Rockford, IL,
USA), using bovine serum albumin as the standard.2.2. AdoMet and AdoHcy in tissue homogenates
For quantiﬁcation of AdoMet and AdoHcy, the homogenate was
centrifuged at 12,000 g, at 4 °C, for 5 min to remove debris and the
supernatant was promptly 10-fold diluted in 0.1 N HCl on ice to a
ﬁnal volume of 250 μL, followed by addition of 156 μL of 10% (v/v)
perchloric acid for deproteinization. After centrifugation for 10 min
at 2000 g, at 4 °C, the supernatant was subjected to a weak
anion-exchange solid-phase extraction procedure using a Waters
Oasis HLB 3 cc (30 mg) extraction column (Waters, Milford, MA,
USA) and analyzed by stable-isotope dilution liquid chromatography–
tandem mass spectrometry, as previously described in detail [12].2.3. Plasma tHcy concentration
Total plasma homocysteine concentrations were measured with a
high-performance liquid chromatography procedure with reverse
phase separation and ﬂuorescence detection, as described previously
[13].2.4. Protein hydrolysis
After centrifugation of the homogenate for 5 min at 12,000 g at
4 °C to remove debris, a 50 μL aliquot of the homogenate supernatant
was mixed with an equal volume of 40% (w/v) trichloroacetic acid.
After centrifugation at 4 °C, 16,000 g, for 10 min, the supernatant
was removed and the pellet was washed twice with 1 mL of
ice-cold acetone and allowed to dry at room temperature. Protein hy-
drolysis was carried out at 110 °C with 6 N HCl for about 20 h in
capped glass vials. The hydrolysates were dried under a gentle stream
of nitrogen gas and stored at −20 °C until use.Table 1
Composition of diets.
Methionine
(g/kg)
Folic acid
(mg/kg)
Vitamin B12
(mg/kg)
Vitamin B6
(mg/kg)
Standard rodent chow
(control)
3.8 2.0 0.03 70.0
High methionine diet (HM) 7.7 2.0 0.03 70.0
Low B vitamins diet (LV) 3.8 0.08 0.01 0.01
High methionine and low B
vitamins diet (HMLV)
7.7 0.08 0.01 0.012.5. Levels of methylarginines in plasma and protein hydrolysates
Unmethylated L-arginine (Arg) and its methylated forms (MMA,
ADMA and SDMA) in plasma and tissue protein hydrolysates were
determined by high-performance liquid chromatography with ﬂuo-
rescence detection, as previously described [14,15]. Brieﬂy, after sam-
ple cleanup by cationic solid-phase extraction (MCX 1 cc cartridges,
Waters Oasis, Milford, MA, USA), the analytes were derivatized
with a reagent containing ortho-phthaldialdehyde (18.7 mM) and
3-mercaptopropionic acid (28.7 mM). Chromatographic separation
of the ﬂuorescent derivatives was performed on a Chromolith Perfor-
mance RP-18e column (100 × 4.6 mm) protected by a matching
guard cartridge (10 × 4.6 mm) from Merck (Darmstadt, Germany).
Homoarginine was used as internal standard. The levels of MMA,
ADMA and SDMA in tissue protein hydrolysates were expressed as
fractions of total arginine (tArg) content.2.6. Histone arginine methylation
The degree of asymmetric dimethylation of histone residues H4R3,
H3R17 and H3R8 was analyzed by Western blotting. Histone proteins
were extracted from tissues using the EpiSeeker Histone Extraction
Kit (Abcam, Cambridge, UK) following the manufacturer's protocol,
separated on 15% SDS-polyacrylamide gels and transferred onto
Hybond-P poly(vinylidene diﬂuoride) membranes (GE Healthcare,
Chalfont St. Giles, Buckinghamshire, UK). The membranes were
probed overnight at 4 °C with primary antibodies diluted in 5%
non-fat milk in TBST: mouse monoclonal anti-H4 (Abcam, Cambridge,
UK) 1:1000; mouse monoclonal anti-H3 (Active Motif, Rixensart,
Belgium) 1:2000; rabbit polyclonal anti-H4R3me2a (Active Motif,
Rixensart, Belgium) 1:2000; rabbit polyclonal anti-H3R17me2a
(Active Motif, Rixensart, Belgium) 1:1000; rabbit polyclonal anti-
H3R8me2a (Active Motif, Rixensart, Belgium) 1:3000. Secondary an-
tibody incubation was performed for 2 h at room temperature with
horse-radish peroxidase-conjugated anti-rabbit IgG (Cell Signaling,
Danvers, MA, USA; 1:2000) or anti-mouse IgG (Jackson Immuno Re-
search, Suffolk, UK; 1:4000). The chemiluminescence reaction was ac-
complished by incubating membranes with the developer solution
(ECL + Plus Western blotting detection system; GE Healthcare,
Chalfont St. Giles, Buckinghamshire, UK) and signal was detected
using a ChemiDoc System (BioRad, Hercules, CA, USA). The signal cor-
responding to each methylationmark was normalized with the one of
the corresponding total histone.2.7. Statistical analysis
Data in text and tables are presented as mean ± SD. Data in ﬁgures
is represented by box-and-whiskers plots: each box is the interquartile
range, the horizontal line bisecting the box is the median and whiskers
are theminimum andmaximum values. Differences between two inde-
pendent groups were analyzed by the Mann–Whitney U test. The
Spearman's testwas used for correlation analysis. Statistical signiﬁcance
was accepted at P b 0.05. In the graphed and tabled data, ⁎, ⁎⁎, and ⁎⁎⁎
denote P values lower than 0.05, 0.01, and 0.001, respectively.3. Results
Plasma tHcy level was 4.8 ± 0.9 μmol/L in rats fed the standard
chow. Administration of the methionine-enriched diet (HM) increased
tHcy levels to 22.7 ± 6.6 μmol/L and higher levels (34.8 ± 14.8 μmol/L)
were found in rats maintained on the low B vitamins diet (LV). Hyper-
homocysteinemia was even more pronounced (83.8 ±34.9 μmol/L)
in rats fed the methionine-enriched diet deﬁcient in B vitamins
(HMLV).
Fig. 2. Effect of diets on the levels of free ADMA in plasma (A) and protein-incorporated
ADMA in liver, heart and brain (B). Rats were fed, for 8 weeks, with a standard rodent
chow (control), a methionine-enriched diet (HM), a B vitamins deﬁcient diet (LV) or a
methionine-enriched diet deﬁcient in B vitamins (HMLV). The levels of protein-
incorporated ADMAwere normalized to total arginine content and expressed as percent-
age of average level in control diet group. Each box represents the interquartile range, and
the horizontal line bisecting it is the median and whiskers are the minimum and maxi-
mum values. ⁎P b 0.05, ⁎⁎P b 0.01 and ⁎⁎⁎P b 0.001, diet versus control.
Table 2
Effect of diets on tissue MMA/tArg (×103), ADMA/tArg (×103) and SDMA/tArg (×103)
ratios after 8 weeks of treatment.
Control HM LV HMLV
Liver
MMA/tArg 0.51 ± 0.02 0.52 ± 0.02 0.52 ± 0.03 0.50 ± 0.02
ADMA/tArg 1.02 ± 0.05 1.08 ± 0.06⁎ 1.07 ± 0.05 1.01 ± 0.03
SDMA/tArg 0.61 ± 0.05 0.61 ± 0.02 0.62 ± 0.04 0.58 ± 0.01
Heart
MMA/tArg 0.37 ± 0.02 0.43 ± 0.11 0.42 ± 0.12 0.36 ± 0.05
ADMA/tArg 1.52 ± 0.12 1.44 ± 0.07 1.40 ± 0.11⁎ 1.38 ± 0.08⁎
SDMA/tArg 0.27 ± 0.02 0.26 ± 0.02 0.26 ± 0.06 0.25 ± 0.00
Brain
MMA/tArg 3.26 ± 0.68 3.94 ± 0.70⁎ 4.22 ± 0.76⁎⁎ 4.04 ± 0.94
ADMA/tArg 6.45 ± 0.86 6.25 ± 0.64 5.83 ± 0.34⁎ 5.60 ± 0.57⁎⁎
SDMA/tArg 1.75 ± 0.25 1.92 ± 0.21 2.01 ± 0.23⁎ 1.90 ± 0.23
⁎ P b 0.05.
⁎⁎ P b 0.01.
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hyperhomocysteinemic rats
In order to ascertain whether the diets affected tissue methylation
capacity, we measured the levels of AdoMet and AdoHcy in liver,
heart and brain. Dietary methionine enrichment alone did not affect
AdoMet and AdoHcy levels. However, nutritional B vitamins depriva-
tion, either alone or in combination with methionine enrichment,
affected AdoMet and AdoHcy levels in a tissue-speciﬁc manner. Rats
fed the LV diet had decreased (P b 0.01) AdoMet levels in liver
(434.6 ± 87.1 nmol/g protein) and in heart (226.2 ± 18.0 nmol/g
protein), compared with controls (569.6 ± 86.8 nmol/g protein in
liver and 322.1 ± 105.7 nmol/g protein in heart). Dietary B vitamins
deﬁciency in combination with methionine enrichment did not affect
tissue AdoMet levels. Animals fed the LV diet had higher (P b 0.01)
hepatic levels of AdoHcy (177.9 ± 15.0 nmol/g protein) than animals
fed the standard chow (153.9 ± 15.5 nmol/g protein), but AdoHcy
levels in other tissues were not affected. Rats fed the HMLV diet had
increased levels of AdoHcy in liver (209.5 ± 18.9 nmol/g protein)
and in heart (27.6 ± 10.0 nmol/g protein) when compared to con-
trols (153.9 ± 15.5 nmol/g protein in liver and 9.2 ± 4.1 nmol/g
protein in heart) (P b 0.001). AdoMet/AdoHcy ratios in the LV and
HMLV diet groups were lower (P b 0.05) in liver (LV: 2.5 ± 0.6;
HMLV: 2.7 ± 0.5) and heart (LV: 16.9 ± 7.2; HMLV: 14.2 ± 4.8),
compared with controls (liver: 3.7 ± 0.6; heart: 35.3 ± 8.2). There-
fore, dietary restriction of B vitamins in combination with methionine
enrichment in this model may reduce cellular methylation capacity in
liver and heart. No differences in AdoMet and AdoHcy levels were
observed in brain.
3.2. Decreased levels of free ADMA in plasma of hyperhomocysteinemic
rats
The HM, LV and HMLV diets resulted in signiﬁcantly lower levels
of free ADMA in plasma than the control diet (Fig. 2A). Free SDMA
levels were lower (P b 0.001) in animals fed the HM diet (0.28 ±
0.02 μM) compared with controls (0.31 ± 0.04 μM). The levels of
free MMA in plasma were below the limit of detection of the method.
Free arginine concentration in plasma averaged 72.5 ±27.9 μM and
was not affected by diet manipulation.
3.3. Disturbed protein arginine methylation status in heart and brain, but
not in liver, of hyperhomocysteinemic rats
The levels of protein-incorporated MMA, ADMA and SDMA in
tissue homogenates were regarded as indicators of protein arginine
methylation status. The level of each methylarginine species was
normalized to total arginine content (tArg), which was deﬁned as the
sum of unmethylated L-arginine and methylated arginine residues.
Total protein-incorporated arginine level in all animals averaged
367 ± 38 nmol/mg protein in liver, 298 ± 24 nmol/mg protein in
heart and 403 ± 35 nmol/mg protein in brain, and didn't change
between diets.
The overall amount of protein-incorporated methylarginines
accounted for approximately 0.2% of total arginine content in liver
and heart and for 1.2% of total arginine content in brain. The average
level of each methylarginine species in brain was at least 3-fold
higher than in liver and heart (Table 2).
Animals subjected to the methionine-enriched diet had in average
5.5% higher ADMA/tArg ratios in hepatic proteins and 20.7% higher
MMA/tArg ratios in brain than animals fed the standard chow,
suggesting that increased methionine availability enhances protein
arginine methylation in these tissues. The degree of arginine methyla-
tion of the heart proteome was not affected by dietary methionine
overloading (Table 2).B vitamins deprivation decreased ADMA/tArg ratios in heart (7.5%
lower) and brain (9.6% lower), but not in liver (Fig. 2B). Interestingly,
animals fed the LV diet had higher levels of protein-incorporated
MMA (29.4% higher) and SDMA (14.7% higher) in brain than controls.
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by the LV diet (Table 2).
Dietary methionine enrichment in combination with B vitamins
deprivation further decreased ADMA/tArg ratios in heart and liver
(by 9.3% and 13.2%, respectively) (Fig. 2B). In animals fed the HMLV
diet, the average SDMA/tArg ratio in heart was 8.0% lower (borderline
signiﬁcance) than in controls (Table 2).
In heart, ADMA/tArg and SDMA/tArg ratios correlated negatively
with AdoHcy level and positively with AdoMet/AdoHcy ratio. In
brain, both MMA/tArg and SDMA/tArg ratios were positively correlat-
ed with AdoMet and AdoHcy levels, but did not correlate with
AdoMet/AdoHcy ratio. In liver and heart, MMA/tArg ratio correlated
positively and strongly with both ADMA/tArg and SDMA/tArg ratios.
However, in brain, MMA/tArg ratio was found to be negatively corre-
lated with ADMA/tArg ratio and positively correlated with SDMA/
tArg ratio (Table 3).Fig. 3. Effect of diet-induced Hcy elevation on histone arginine methylation degree in
liver, heart and brain. The degrees of asymmetric dimethylation of histone H4 at arginine
3 (H4R3me2a) and of histone H3 at arginines 17 (H3R8me2a) and 8 (H3R17me2a) in
whole preparations of liver, heart and brain from animals fed either a standard rodent
chow (control) or a methionine-enriched diet deﬁcient in B vitamins (HMLV) were eval-
uated by Western blotting. (A) The signal corresponding to each methylation mark was
normalized with that of the total histone (H3 or H4) and deﬁned as methylation degree.
Densitometry was performed on bands corresponding to 4 or 5 animals subjected to the
HMLV diet and 4 or 5 controls. Each box represents the interquartile range, the horizontal
line bisecting it is the median and whiskers are the minimum and maximum values.3.4. Decreased methylation of histone H3 at arginine 8 in brain of
hyperhomocysteinemic rats
We have assessed the effect of diet-induced Hcy elevation on the
methylation degree of a speciﬁc class of proteins, namely histones.
The rationale for this choice was that histone arginine methylation
has been very well studied, and it is an epigenetic mark crucially in-
volved in the regulation of gene expression [10]. Since diet-induced
HHcy affected the levels of protein-incorporated ADMA, and not those
of SDMA, and based on the commercial availability of the antibodies,
we have focused on the asymmetric dimethylation of 3 histone arginine
residues, namely arginine 4 of histone H4 (H4R3me2a) and arginines 8
and 17 of histone H3 (H3R8me2a and H3R17me2a). Analysis was
performed onwhole preparations of heart, liver and brain from animals
exposed to the control and HMLV diets. We selected the HMLV group
because this diet induced the most signiﬁcant decrease in tissue
protein-incorporated ADMA levels (Fig. 2B). The H4R3me2a and
H3R17me2a methylation marks were not affected by the HMLV diet
in all tissues (Fig. 3A). H3R8me2a was not present in heart histone
extracts and was not affected in liver. However, H3R8me2a in brain ofTable 3
Correlation analysis.
MMA/tArg ADMA/tArg SDMA/tArg
Liver
AdoMet (nmol/g prot) −0.05 −0.36⁎ −0.23
AdoHcy (nmol/g prot) −0.20 −0.29 −0.27
AdoMet/AdoHcy 0.13 −0.01 0.01
MMA/tArg – 0.59⁎⁎⁎ 0.60⁎⁎⁎
ADMA/tArg 0.59⁎⁎⁎ – 0.74⁎⁎⁎
SDMA/tArg 0.60⁎⁎⁎ 0.74⁎⁎⁎ –
Heart
AdoMet (nmol/g prot) −0.08 −0.12 −0.08
AdoHcy (nmol/g prot) −0.16 −0.50⁎⁎ −0.53⁎⁎
AdoMet/AdoHcy 0.01 0.38⁎ 0.45⁎
MMA/tArg – 0.62⁎⁎⁎ 0.57⁎⁎⁎
ADMA/tArg 0.62⁎⁎⁎ – 0.86⁎⁎⁎
SDMA/tArg 0.57⁎⁎⁎ 0.86⁎⁎⁎ –
Brain
AdoMet (nmol/g prot) 0.55⁎⁎⁎ −0.10 0.58⁎⁎⁎
AdoHcy (nmol/g prot) 0.36⁎ 0.08 0.37⁎
AdoMet/AdoHcy 0.01 −0.13 0.05
MMA/tArg – −0.45⁎⁎ 0.90⁎⁎⁎
ADMA/tArg −0.45⁎⁎ – −0.41⁎⁎
SDMA/tArg 0.90⁎⁎⁎ −0.41 –
Correlation analysis was performed by calculating the Spearman's rank correlation
coefﬁcients between the levels of AdoMet and AdoHcy, AdoMet/AdoHcy ratios and
ratios of methylated arginine residues to total arginine content in liver, heart and brain.
⁎ P b 0.05.
⁎⁎ P b 0.01.
⁎⁎⁎ P b 0.001.
⁎P b 0.05, ⁎⁎P b 0.01 and ⁎⁎⁎P b 0.001, HMLV versus control. (B) RepresentativeWestern
blot images of H4, H4R3me2a, H3, H3R17me2a and H3R8me2a in brain.animals exposed to the HMLV diet was approximately 70% lower than
in controls (Fig. 3A and B).4. Discussion
Our study shows that in diet-induced HHcy global protein arginine
methylation is disturbed in a tissue-speciﬁc manner. Speciﬁcally, the
degree of asymmetric dimethylation in heart and brain is decreased,
but not in liver. In brain, proteins display an increased content in
MMA and SDMA residues. Moreover, we have identiﬁed a disturbed
epigenetic mark on histone H3 in this tissue, suggesting for the ﬁrst
time that Hcy elevation affects histone arginine methylation patterns.
The present study was conducted to determine the impact of
diet-induced Hcy elevation on global protein arginine hypomethylation
in several tissues. The results are summarized in Table 4. We have in-
duced HHcy in rats by dietarymethionine enrichment (HM), B vitamins
deprivation (LV) or B vitamins deprivation combined with methionine
enrichment (HMLV). Hepatic levels of AdoHcy in animals fed the LV
and HMLV diets were higher when compared with controls. Only ani-
mals fed the HMLV diet displayed lower levels of AdoHcy in heart com-
pared with controls. Accordingly, B vitamins deﬁciency, either with or
without methionine enrichment, decreased AdoMet/AdoHcy ratios in
both tissues. Thus, cellular methylation capacity in liver and heart may
be decreased in HHcy due to B vitamins deﬁciency.
Table 4
Summary of the changes concerning metabolite levels and protein-incorporated
methylarginine levels in rats exposed to the three different diets (high methionine,
HM, low B vitamins, LV, and combined high methionine and low B vitamins, HMLV),
in comparison with the control group.
HM LV HMLV
Plasma
tHcy ↑↑ ↑↑ ↑↑
ADMA ↓↓ ↓↓ ↓↓
SDMA ↓↓ NC NC
Liver
AdoMet NC ↓↓ NC
AdoHcy NC ↑ ↑↑
AdoMet/AdoHcy NC ↓↓ ↓↓
MMA/tArg NC NC NC
ADMA/tArg ↑ NC NC
SDMA/tArg NC N.C. NC
Heart
AdoMet ↓↓ ↓↓ NC
AdoHcy NC NC ↑↑
AdoMet/AdoHcy NC ↓↓ ↓↓
MMA/tArg NC NC NC
ADMA/tArg NC ↓ ↓
SDMA/tArg NC NC NC
Brain
AdoMet NC ↑ NC
AdoHcy NC NC NC
AdoMet/AdoHcy NC NC NC
MMA/tArg ↑↑ ↑↑ NC
ADMA/tArg NC ↓ ↓
SDMA/tArg NC ↑ NC
NC— no change. ↑— b20% increase. ↑↑—>20% increase. ↓— b20% decrease. ↓↓—>20%
decrease.
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global protein arginine methylation status, we have determined the
levels of free and protein-incorporated methylarginines in plasma
samples and tissue homogenates, respectively. The plasma levels of
free ADMA in hyperhomocysteinemic animals were markedly lower
than in controls (Fig. 2A). Since ADMA inhibits the endothelial nitric
oxide synthase (eNOS), an enzyme crucial for vascular function and
homeostasis, several authors have suggested that ADMA elevation
mediates the endothelial dysfunction observed in HHcy by reducing
the production of nitric oxide (NO) [16–20]. However, a view gaining
prominence is that they are either not related to each other or are
both increased due to inadequate renal clearance [21–24]. Important-
ly, we recently observed that CBS-deﬁcient patients, presenting
severe HHcy and high risk of vascular disease, have normal plasma
levels of ADMA, supporting the notion that ADMA is not implicated
in the vascular toxicity associated with HHcy [23].
In line with the concept that Hcy elevation elicits cellular
hypomethylation via AdoHcy build-up, we hypothesized that the
decrease in plasma ADMA levels observed in our HHcy model was a
reﬂection of protein hypomethylation. We measured the levels of
methylated arginines in protein hydrolysates of the tissues as a
more direct indication of protein arginine methylation degree. Sever-
al differences were observed concerning the effect of the different
diets on tissue protein-incorporated MMA, ADMA and SDMA levels
(Fig. 2B). In liver, the HM diet elicited a slight increase in protein-
incorporated ADMA levels (when compared to controls), but it did
not affect SDMA levels. The LV and HMLV diets did not produce
changes in the levels of protein-incorporated MMA, ADMA and
SDMA in liver, although the levels of AdoHcy, as well as AdoMet/
AdoHcy ratios, were signiﬁcantly affected. We conclude that protein
arginine methylation status in liver is not disturbed in diet-induced
Hcy elevation. Noteworthy, the liver expresses a set of unique
enzymes involved in the one-carbon and Hcy metabolisms that
may avert the effect of AdoHcy elevation on protein methylation.
For instance, guanidinoacetate N-methyltransferase (GAMT) andphosphatidylethanolamine N-methyltransferase (PEMT), which are re-
quired for the production of creatine and phosphatidylcholine,
respectively, consume the majority of methyl groups in liver [25] and
both are inhibited by AdoHcy [26,27]. Other extensive transmethylation
reaction in liver is the one catalyzed by glycine N-methyltransferase
(GNMT), which is highly expressed in liver and hardly in other tissues.
The expression of GNMT is up-regulated in response to methionine-
induced HHcy [28], in light with the proposed role of GNMT as
amethyl group buffering enzyme in the hepatic one-carbonmetabolism.
In heart, methionine enrichment alone did not affect the levels of
protein-incorporatedMMA, ADMA and SDMA, suggesting that increased
methionine availability does not cause protein hypermethylation, at
least at arginine residues. It is important to note thatMAT II, the predom-
inant isoform in heart [29], saturates at low concentrations of methio-
nine. This mechanism may explain why methionine supplementation
is ineffective in increasing AdoMet synthesis. We conclude that global
protein arginine methylation status in heart is not modulated by dietary
methionine intake. Interestingly, a decrease in the levels of protein-
incorporated ADMAwas observed in animals receiving the diet deﬁcient
in B vitamins. In addition, the levels of protein-incorporated ADMA, as
well as those of SDMA, correlated negatively with AdoHcy level and
positively with AdoMet/AdoHcy ratio. We have shown that, in heart, B
vitamins deﬁciency elicits protein arginine hypomethylation due to
AdoHcy elevation.
Protein arginine methylation status was also analyzed in brain
homogenates. Interestingly, in controls, the levels of protein-incorporated
MMA, ADMA and SDMA in brain were at least 3-fold higher than in liver
and heart. Therefore, we conclude that the brain proteome is subject to
methylation at arginine residues at a higher extent than the liver and
heart proteomes. The levels of protein-incorporated ADMA in brain
decreased in both B vitamins deﬁcient diet groups (LV and HMLV)
after 8 weeks of dietary manipulation. However, neither SDMA nor
MMA mean levels decreased in these groups, but rather increased
in the LV group (by 14.7% and 20.7%, respectively, compared with
controls) suggesting increased symmetric dimethylation. We specu-
late that, in brain, asymmetric dimethylation is reduced, leading to
accumulation of MMA, and the later is then used as substrate by
type II PRMTs to form SDMA. Supporting this possibility, MMA/tArg
ratio in brain correlated negatively with ADMA/tArg ratio and posi-
tively with SDMA/tArg ratio (Table 3). Intriguingly, the levels of
AdoMet and AdoHcy in brain were not signiﬁcantly affected by
diets, which would argue against brain speciﬁc PRMTs inhibition by
AdoHcy. Noteworthy, the levels of AdoMet and AdoHcy in the tissues
result from a ﬁne-tuned balance between the rates of their formation
and degradation, and the concentrations of AdoMet and AdoHcy do
not necessarily reﬂect their turnovers. Therefore, the hypothesis
that the B vitamins deﬁcient diets affected the turnover of AdoMet
and AdoHcy in brain, and thus their availability for transmethylation
reactions, ought not to be excluded and should be addressed in detail
in future investigations.
In an attempt to demonstrate a pathophysiological implication of the
global protein arginine methylation disturbance observed in our HHcy
model, we then focused on a speciﬁc class of proteins, namely histones.
As previously referred, the levels of protein-incorporated ADMAwere af-
fected by diets, so we focused on asymmetric dimethylation of 3 arginine
residues on histones H3 and H4 (H3R8, H3R17 and H4R3). In addition,
we selected the HMLV group because this diet induced the most signiﬁ-
cant decrease in tissue protein-incorporated ADMA levels (Fig. 2B). The
degree of H4R3me2a and H3R17me2a methylation did not differ from
that in controls in all tissues examined, suggesting that these epigenetic
marks are not affected in HHcy. However, and interestingly, the amount
of the H3R8me2amark in brain from animals fed the HMLV diet was ap-
proximately 70% lower than in controls. Blythe and colleagues showed
that in early embryos β-catenin, a protein with a key role in mammalian
neural development, recruits PRMT2 to target promoters, thereby
establishing the H3R8me2a mark. This event is necessary to deﬁne key
1714 R. Esse et al. / Biochimica et Biophysica Acta 1832 (2013) 1708–1714organizer genes for later expression and to initiate the dorsal develop-
ment program [30]. However, in our study, dietary treatment started at
adulthood, which excludes any effect of H3R8 hypomethylation on
brain formation. Until recently, histone arginine methylation was taken
as a stable modiﬁcation occurring mainly during cell and tissue differen-
tiation and development. However, the discovery of histone
demethylases has changed this concept, and histone arginine methyla-
tion is now accepted as a reversible modiﬁcation and an important epi-
genetic mechanism of gene expression regulation [10]. In the context of
our study, we have observed that Hcy elevation elicits H3R8me2a de-
crease in brain. The identiﬁcation of genes whose expression is affected
by reduction of the H3R8me2a mark may provide new insights on the
molecular mechanisms underlying Hcy-related pathologies.
The potential role of protein arginine methylation disturbance in
the etiology of Hcy-related diseases has been largely neglected. Taken
together, our results show an impairment of global protein arginine
methylation in rats under HHcy induced by B vitamins deﬁciency, albeit
in a tissue-speciﬁc manner. Namely, protein arginine methylation is dis-
turbed in heart and in brain, but not in liver. We reason that the future
identiﬁcation of proteins that undergo differential methylation in heart
and brain in the context of Hcy elevationmay uncover novel pathophys-
iological mechanisms linking HHcy and neurological and vascular dis-
eases. In addition, diet-induced Hcy elevation reduces the H3R8me2a
mark in brain, warranting future investigation to disclose the conse-
quences of this epigenetic derangement for brain homeostasis.
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